申请人:VentiRx Pharmaceuticals, Inc.
公开号:US20160129010A1
公开(公告)日:2016-05-12
Provided are compositions and methods useful for modulation of signaling through the Toll-like receptors TLR7 and/or TLR8. The compositions and methods have use in treating or preventing disease, including cancer, autoimmune disease, infectious disease, inflammatory disorder, graft rejection, and graft-versus-host disease.
提供的是用于调节Toll样受体TLR7和/或TLR8信号传导的组合物和方法。这些组合物和方法可用于治疗或预防疾病,包括癌症、自身免疫性疾病、传染病、炎症性疾病、移植排斥和移植物抗宿主病。